193 related articles for article (PubMed ID: 26732650)
21. ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor.
Lavin MF; Kozlov S; Gatei M; Kijas AW
Biomolecules; 2015 Oct; 5(4):2877-902. PubMed ID: 26512707
[TBL] [Abstract][Full Text] [Related]
22. Biased exon/intron distribution of cryptic and de novo 3' splice sites.
Královicová J; Christensen MB; Vorechovský I
Nucleic Acids Res; 2005; 33(15):4882-98. PubMed ID: 16141195
[TBL] [Abstract][Full Text] [Related]
23. Decoding of exon splicing patterns in the human RUNX1-RUNX1T1 fusion gene.
Grinev VV; Migas AA; Kirsanava AD; Mishkova OA; Siomava N; Ramanouskaya TV; Vaitsiankova AV; Ilyushonak IM; Nazarov PV; Vallar L; Aleinikova OV
Int J Biochem Cell Biol; 2015 Nov; 68():48-58. PubMed ID: 26320575
[TBL] [Abstract][Full Text] [Related]
24. Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathways.
Tang S; Hou Y; Zhang H; Tu G; Yang L; Sun Y; Lang L; Tang X; Du YE; Zhou M; Yu T; Xu L; Wen S; Liu C; Liu M
Cell Cycle; 2015; 14(12):1908-24. PubMed ID: 25970706
[TBL] [Abstract][Full Text] [Related]
25. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
26. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
27. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
[TBL] [Abstract][Full Text] [Related]
28. Rad17 recruits the MRE11-RAD50-NBS1 complex to regulate the cellular response to DNA double-strand breaks.
Wang Q; Goldstein M; Alexander P; Wakeman TP; Sun T; Feng J; Lou Z; Kastan MB; Wang XF
EMBO J; 2014 Apr; 33(8):862-77. PubMed ID: 24534091
[TBL] [Abstract][Full Text] [Related]
29. Cancer-Associated Substitutions in RNA Recognition Motifs of PUF60 and U2AF65 Reveal Residues Required for Correct Folding and 3' Splice-Site Selection.
Kralovicova J; Borovska I; Kubickova M; Lukavsky PJ; Vorechovsky I
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664474
[TBL] [Abstract][Full Text] [Related]
30. Lyn tyrosine kinase promotes silencing of ATM-dependent checkpoint signaling during recovery from DNA double-strand breaks.
Fukumoto Y; Kuki K; Morii M; Miura T; Honda T; Ishibashi K; Hasegawa H; Kubota S; Ide Y; Yamaguchi N; Nakayama Y; Yamaguchi N
Biochem Biophys Res Commun; 2014 Sep; 452(3):542-7. PubMed ID: 25173936
[TBL] [Abstract][Full Text] [Related]
31. Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks.
Pennisi R; Antoccia A; Leone S; Ascenzi P; di Masi A
FEBS J; 2017 Aug; 284(15):2378-2395. PubMed ID: 28631426
[TBL] [Abstract][Full Text] [Related]
32. Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Hollingworth R; Horniblow RD; Forrest C; Stewart GS; Grand RJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28855246
[TBL] [Abstract][Full Text] [Related]
33. An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.
Pastor T; Talotti G; Lewandowska MA; Pagani F
Nucleic Acids Res; 2009 Nov; 37(21):7258-67. PubMed ID: 19773425
[TBL] [Abstract][Full Text] [Related]
34. The DNA damage response activates HPV16 late gene expression at the level of RNA processing.
Nilsson K; Wu C; Kajitani N; Yu H; Tsimtsirakis E; Gong L; Winquist EB; Glahder J; Ekblad L; Wennerberg J; Schwartz S
Nucleic Acids Res; 2018 Jun; 46(10):5029-5049. PubMed ID: 29596642
[TBL] [Abstract][Full Text] [Related]
35. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
36. Identification of new splice sites used for generation of rev transcripts in human immunodeficiency virus type 1 subtype C primary isolates.
Delgado E; Carrera C; Nebreda P; Fernández-García A; Pinilla M; García V; Pérez-Álvarez L; Thomson MM
PLoS One; 2012; 7(2):e30574. PubMed ID: 22363449
[TBL] [Abstract][Full Text] [Related]
37. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
Buratti E; Dhir A; Lewandowska MA; Baralle FE
Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
[TBL] [Abstract][Full Text] [Related]
38. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
39. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
Priya B; Ravi S; Kirubakaran S
Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
[TBL] [Abstract][Full Text] [Related]
40. ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming.
Liu X; Hu M; Liu P; Jiao M; Zhou M; Lee AK; Li F; Li CY
Cancer Res; 2020 Apr; 80(8):1669-1680. PubMed ID: 32060145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
